NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

Evaluate,

I believe your conclusions are correct but I do not wish to hazard a guess as to how many might not take DCVax at crossover since Dr. Linda Liau did not. She only hinted that there might be some. This suggests a group of late progressers in the SOC and, to a lesser extent, earlier progressors in the treatment group that might think that they had already received the vaccine and would not have any more benefit from taking the option for whatever reason. This might include cost of checkpoint inhibitors or other treatments or desire to try another trial if permitted to do so.